Stocktoria

Inhibikase Therapeutics, Inc. IKT

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-12-23 · LEI

Inhibikase Therapeutics, Inc. institutional holders

InvestorSharesValue% of company
MILLENNIUM MANAGEMENT LLC4,028,102$8.2M3.06%
TWO SIGMA INVESTMENTS, LP806,264$1.6M0.61%
AQR CAPITAL MANAGEMENT LLC468,197$950,4400.36%
CITADEL ADVISORS LLC74,349$150,9280.06%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.